கிணறுகள் ஃபார்கோ பயோடெக் பெருநிறுவன நுழைவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021 News provided by Share this article Share this article AUSTIN, Texas, April 1, 2021 /PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, today announced it will participate in two virtual investor conferences in April 2021.   Conference Details Conference Date: Tuesday, April 6 and Thursday, April 8 Participants: Anthony G. Quinn, M.B. Ch.B., Ph.D., Aeglea s president and chief executive officer and Michael C. Hanley, Aeglea s chief commercial officer Conference Name: 20 Conference Date: Monday, April 12 through Thursday, April 15

United statesMichaelc hanleyAeglea biotherapeuticsAnthonyg quinnPrnewswire aeglea biotherapeutics incAeglea biotherapeutics incWells fargo biotech corporate accessAnnual needham virtual healthcare conferenceRare pediatric diseaseBreakthrough therapyHealth care amp hospitalsMedical pharmaceuticalsஒன்றுபட்டது மாநிலங்களில்கிணறுகள் ஃபார்கோ பயோடெக் பெருநிறுவன நுழைவுஆண்டு நீட்ஹாம் மெய்நிகர் சுகாதாரம் மாநாடுரேர் குழந்தை நோய்